135 related articles for article (PubMed ID: 27168261)
1. Economic Costs Avoided by Diagnosing Melanoma Six Months Earlier Justify >100 Benign Biopsies.
Aires DJ; Wick J; Shaath TS; Rajpara AN; Patel V; Badawi AH; Li C; Fraga GR; Doolittle G; Liu DY
J Drugs Dermatol; 2016 May; 15(5):527-32. PubMed ID: 27168261
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data.
Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC
Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of reduced follow-up in malignant melanoma.
Hengge UR; Wallerand A; Stutzki A; Kockel N
J Dtsch Dermatol Ges; 2007 Oct; 5(10):898-907. PubMed ID: 17910672
[TBL] [Abstract][Full Text] [Related]
5. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages.
Alexandrescu DT
Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637
[TBL] [Abstract][Full Text] [Related]
6. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis.
Elliott TM; Whiteman DC; Olsen CM; Gordon LG
Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584
[TBL] [Abstract][Full Text] [Related]
7. The health burden and economic costs of cutaneous melanoma mortality by race/ethnicity-United States, 2000 to 2006.
Ekwueme DU; Guy GP; Li C; Rim SH; Parelkar P; Chen SC
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S133-43. PubMed ID: 22018062
[TBL] [Abstract][Full Text] [Related]
8. A decade of melanomas: identification of factors associated with delayed detection in an academic group practice.
Goodson AG; Florell SR; Boucher KM; Grossman D
Dermatol Surg; 2011 Nov; 37(11):1620-30. PubMed ID: 21790849
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of skin cancer screening for individuals age 14 to 34 years.
Schmitt J; Seidler A; Heinisch G; Sebastian G
J Dtsch Dermatol Ges; 2011 Aug; 9(8):608-16. PubMed ID: 21501381
[TBL] [Abstract][Full Text] [Related]
10. Serial screening for melanoma: measures and strategies that have consistently achieved early detection and cure.
Shore RN; Shore P; Monahan NM; Sundeen J
J Drugs Dermatol; 2011 Mar; 10(3):244-52. PubMed ID: 21369639
[TBL] [Abstract][Full Text] [Related]
11. Melanoma screening: A plan for improving early detection.
Shellenberger R; Nabhan M; Kakaraparthi S
Ann Med; 2016; 48(3):142-8. PubMed ID: 26911192
[TBL] [Abstract][Full Text] [Related]
12. Melanomas detected with the aid of total cutaneous photography.
Feit NE; Dusza SW; Marghoob AA
Br J Dermatol; 2004 Apr; 150(4):706-14. PubMed ID: 15099367
[TBL] [Abstract][Full Text] [Related]
13. An estimate of the annual direct cost of treating cutaneous melanoma.
Tsao H; Rogers GS; Sober AJ
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809
[TBL] [Abstract][Full Text] [Related]
14. Melanoma screening by physicians: time for a policy change in the United States.
Wickenheiser MR; Bordeaux JS; Robinson JK
JAMA Dermatol; 2014 Oct; 150(10):1045-6. PubMed ID: 25188439
[No Abstract] [Full Text] [Related]
15. Cost-Effectiveness of Skin Surveillance Through a Specialized Clinic for Patients at High Risk of Melanoma.
Watts CG; Cust AE; Menzies SW; Mann GJ; Morton RL
J Clin Oncol; 2017 Jan; 35(1):63-71. PubMed ID: 28034073
[TBL] [Abstract][Full Text] [Related]
16. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
Garbe C; Hauschild A; Volkenandt M; Schadendorf D; Stolz W; Reinhold U; Kortmann RD; Kettelhack C; Frerich B; Keilholz U; Dummer R; Sebastian G; Tilgen W; Schuler G; Mackensen A; Kaufmann R
Melanoma Res; 2007 Dec; 17(6):393-9. PubMed ID: 17992123
[TBL] [Abstract][Full Text] [Related]
17. Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma.
Fisher NM; Schaffer JV; Berwick M; Bolognia JL
J Am Acad Dermatol; 2005 Sep; 53(3):393-406. PubMed ID: 16112344
[TBL] [Abstract][Full Text] [Related]
18. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review.
Gordon LG; Rowell D
Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the efficacy of 3D total-body photography with sequential digital dermoscopy in a high-risk melanoma cohort: protocol for a randomised controlled trial.
Primiero CA; McInerney-Leo AM; Betz-Stablein B; Whiteman DC; Gordon L; Caffery L; Aitken JF; Eakin E; Osborne S; Gray L; Smithers BM; Janda M; Soyer HP; Finnane A
BMJ Open; 2019 Nov; 9(11):e032969. PubMed ID: 31712348
[TBL] [Abstract][Full Text] [Related]
20. Increased melanoma risk in Parkinson disease: a prospective clinicopathological study.
Bertoni JM; Arlette JP; Fernandez HH; Fitzer-Attas C; Frei K; Hassan MN; Isaacson SH; Lew MF; Molho E; Ondo WG; Phillips TJ; Singer C; Sutton JP; Wolf JE;
Arch Neurol; 2010 Mar; 67(3):347-52. PubMed ID: 20212233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]